BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9824094)

  • 1. Overexpression of cyclin-D1, bcl-2, and bax proteins, proliferating cell nuclear antigen (PCNA), and DNA-ploidy in squamous cell carcinoma of the oral cavity.
    Staibano S; Mignogna MD; Lo Muzio L; Di Alberti L; Di Natale E; Lucariello A; Mezza E; Bucci E; DeRosa G
    Hum Pathol; 1998 Nov; 29(11):1189-94. PubMed ID: 9824094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic implication of the expression of EGFR, p53, cyclin D1, Bcl-2 and p16 in primary locally advanced oral squamous cell carcinoma cases: a tissue microarray study.
    Solomon MC; Vidyasagar MS; Fernandes D; Guddattu V; Mathew M; Shergill AK; Carnelio S; Chandrashekar C
    Med Oncol; 2016 Dec; 33(12):138. PubMed ID: 27817107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cyclin D1, Ki-67 and PCNA in non-small cell lung cancer: prognostic significance and comparison with p53 and bcl-2.
    Nguyen VN; Mirejovský P; Mirejovský T; Melínová L; Mandys V
    Acta Histochem; 2000 Aug; 102(3):323-38. PubMed ID: 10990069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between prognosis and cell proliferation, apoptosis in squamous cell carcinoma of tongue].
    Yang YP; Qing HY; Cao Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2003 Jan; 38(1):31-4. PubMed ID: 12760773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of bcl-2 and bax in squamous cell carcinomas of the oral cavity.
    Jordan RC; Catzavelos GC; Barrett AW; Speight PM
    Eur J Cancer B Oral Oncol; 1996 Nov; 32B(6):394-400. PubMed ID: 9039223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue.
    Xie X; Clausen OP; De Angelis P; Boysen M
    Cancer; 1999 Sep; 86(6):913-20. PubMed ID: 10491515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of PCNA, p53, Bax, and Bcl-X in oral poorly differentiated and basaloid squamous cell carcinoma: relationships with prognosis.
    Sampaio-Góes FC; Oliveira DT; Dorta RG; Nonogaki S; Landman G; Nishimoto IN; Kowalski LP
    Head Neck; 2005 Nov; 27(11):982-9. PubMed ID: 16136583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Clinical Features and Expression of bcl-2, Cyclin D1, p53, and Proliferating Cell Nuclear Antigen in Syndromic and Nonsyndromic Keratocystic Odontogenic Tumor.
    Ibrahim N; Nazimi AJ; Ajura AJ; Nordin R; Latiff ZA; Ramli R
    J Craniofac Surg; 2016 Jul; 27(5):1361-6. PubMed ID: 27391504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Bcl-2 family proteins and associated clinicopathologic factors predict survival outcome in patients with oral squamous cell carcinoma.
    Camisasca DR; Honorato J; Bernardo V; da Silva LE; da Fonseca EC; de Faria PA; Dias FL; Lourenço Sde Q
    Oral Oncol; 2009 Mar; 45(3):225-33. PubMed ID: 18715811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of Bax, Bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy.
    Wootipoom V; Lekhyananda N; Phungrassami T; Boonyaphiphat P; Thongsuksai P
    Gynecol Oncol; 2004 Sep; 94(3):636-42. PubMed ID: 15350352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of Ki-67 (MIB1), PCNA and p53 in cancer of the oropharynx and oral cavity.
    Sittel C; Ruiz S; Volling P; Kvasnicka HM; Jungehülsing M; Eckel HE
    Oral Oncol; 1999 Nov; 35(6):583-9. PubMed ID: 10705094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of the expression of proliferating cell nuclear antigen, p53, bax, and bcl-2 in oral lichen planus and oral squamous cell carcinoma.
    de Sousa FA; Paradella TC; Carvalho YR; Rosa LE
    Ann Diagn Pathol; 2009 Oct; 13(5):308-12. PubMed ID: 19751907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous apoptosis in laryngeal squamous cell carcinoma is independent of bcl-2 and bax protein expression.
    Jäckel MC; Dorudian MA; Marx D; Brinck U; Schauer A; Steiner W
    Cancer; 1999 Feb; 85(3):591-9. PubMed ID: 10091732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of Bcl-2 and Bax protein expression in the patients with oral squamous cell carcinoma.
    Zhang M; Zhang P; Zhang C; Sun J; Wang L; Li J; Tian Z; Chen W
    J Oral Pathol Med; 2009 Mar; 38(3):307-13. PubMed ID: 18710422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bax protein expression in the carcinogenesis of human oral mucosa].
    Zeng X; Chen Q; Li B; Tan N
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2000 Apr; 18(2):88-90. PubMed ID: 12539337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral squamous cell carcinoma is associated with decreased bcl-2/bax expression ratio and increased apoptosis.
    Loro LL; Vintermyr OK; Liavaag PG; Jonsson R; Johannessen AC
    Hum Pathol; 1999 Sep; 30(9):1097-105. PubMed ID: 10492046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of Bax is correlated with poor prognosis in oral and oropharyngeal carcinoma.
    Ito T; Fujieda S; Tsuzuki H; Sunaga H; Fan G; Sugimoto C; Fukuda M; Saito H
    Cancer Lett; 1999 Jun; 140(1-2):81-91. PubMed ID: 10403545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell kinetics and apoptosis in laryngeal carcinoma patients.
    Georgiou A; Gomatos IP; Pararas NB; Giotakis J; Ferekidis E
    Ann Otol Rhinol Laryngol; 2003 Mar; 112(3):206-13. PubMed ID: 12656410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis-associated markers and clinical outcome in human oral squamous cell carcinomas.
    Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Yamamoto E
    J Oral Pathol Med; 2008 Jul; 37(6):364-71. PubMed ID: 18410312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Msh2, Mlh1, Fhit, p53, Bcl-2, and Bax expression in invasive and in situ squamous cell carcinoma of the uterine cervix.
    Giarnieri E; Mancini R; Pisani T; Alderisio M; Vecchione A
    Clin Cancer Res; 2000 Sep; 6(9):3600-6. PubMed ID: 10999751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.